NVT Logo (4).jpg
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
September 19, 2023 03:56 ET | Novotech
SINGAPORE, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best...
POINT logo light blue (png).png
POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted Radioligands
September 18, 2023 08:00 ET | POINT Biopharma
INDIANAPOLIS and SCHLIEREN-ZURICH, Switzerland, Sept. 18, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery,...
Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry in the College of Science
Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa
September 15, 2023 12:48 ET | Purdue Research Foundation
WEST LAFAYETTE, Ind., Sept. 15, 2023 (GLOBE NEWSWIRE) -- A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries. Open...
Global Clinical Trial Imaging Market
Global Clinical Trial Imaging Market Research Report 2023-2028: Visualizing Medical Research - Rising R&D Investments Boost Clinical Trial Imaging
September 14, 2023 06:53 ET | Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO),...
Logo transparent PNG.png
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
September 14, 2023 06:00 ET | PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
NurExone.png
NurExone Moves Forward Towards Human Clinical Trials, Completes Pre-IND Meeting with the FDA for Proprietary ExoPTEN Drug
September 13, 2023 08:30 ET | NurExone Biologic Inc
The FDA’s response indicated that the planned toxicity study strategy is acceptable under FDA guidelines and large-scale animal studies will not be required. The completed Pre-IND meeting with the...
Indian Ophthalmic Clinical Trials Market
Rising Prevalence of Eye Disorders Drives India's Ophthalmic Clinical Trials Market, Veeda Clinical Research and Catawba Research at the Forefront
September 12, 2023 05:03 ET | Research and Markets
Dublin, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The "India Ophthalmic Clinical Trials Market Size, Share & Trends Analysis Report By Product (Devices, Drugs/Pharmaceuticals), By Indication, By Phase,...
cropped-cropped-Logo-AlgoTx-couleur-1-228x81.png
AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia
September 12, 2023 03:00 ET | AlgoTX
PARIS, Sept. 12, 2023 (GLOBE NEWSWIRE) --  AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing targeted, first-in-class therapeutics for peripheral neuropathic pain,...
visiongain Logo.png
In Silico Clinical Trials market is projected to grow at a CAGR of 8% by 2033: Visiongain
September 08, 2023 07:30 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled In Silico Clinical Trials Market Report 2023-2033: Forecasts by Application (Drug Development, Medical Device Development), by End-users (Pharmaceutical...
NVT Logo (4).jpg
Novotech Releases Comprehensive Global Landscape Report on Gallbladder Cancer Clinical Trials
September 07, 2023 17:49 ET | Novotech
BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report...